跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xiprolife - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xiprolife
Approved
STANDARD
Xiprolife
Aishwarya Lifesciences
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
144812667f42102d
Company
Aishwarya Lifesciences
Type
Standard
Approval Details
Approval Id
144812667f42102d
Drug Approval Philippines Name
Xiprolife
Product Name
Xiprolife
Registration Number
DRP-13414
Brand Name
Xiprolife
Generic Name
Ciprofloxacin
Dosage Form
Solution for IV Infusion
Dosage Strength
2 mg/mL (200 mg/100 mL)
Manufacturer
Aishwarya Lifesciences
Importer
Pharmakon Biotec Inc.
Distributor
Pharmakon Biotec Inc.
Issuance Date
27 February 2023
Expiry Date
27 February 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
144812667f42102d
Type
Standard
Back to Philippines FDA Approvals